Pirkka T. Pekkarinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pirkka T. Pekkarinen has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
- Matti Reinikainen
Institute of Clinical Medicine University of Eastern Finland Kuopio Finland
9 shared publications - Markus Benedikt Skrifvars
Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital and University of Helsinki, Finland
7 shared publications - Eliisa Kekäläinen
Translational Immunology Research Program University of Helsinki and Helsinki University Hospital Helsinki Finland
6 shared publications T. Petteri Arstila
Haartman Institute, Department of Bacteriology and Immunology, Immunobiology Research Program, University of Helsinki, PB 21, Helsinki 00014, Finland
6 shared publicationsMarkus B. Skrifvars
Helsinki Univ Hosp, Helsinki, Finland
4 shared publications- Seppo Meri
Helsinki University Hospital, The University of Helsinki and HUSLAB Helsinki Finland
4 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (10) , e70303
Increased Output of Recent Thymic Emigrants Contributes to Reconstitution of T‐Cell Pool During Recovery From COVID‐19
Acute coronavirus disease 2019 (COVID‐19) causes marked T‐cell lymphopenia, with recovery potentially driven by peripheral proliferation or increased thymic output of recent thymic emigrants (RTEs). We examined the relative contribution of these mechanisms by analyzing naïve T‐cell and RTE dynamics in 63 patients sampled at 1–3 timepoints during and after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Overall frequencies of naïve CD4+ and CD8+ T cells remained stable during convalescence. In a female‐biased subcohort with paired samples, CD31+ CD4+ and CD21+ CD8+ RTE‐enriched subset frequencies increased from acute to late convalescence (LC) stage. Across the full cohort, a significant increase was confirmed for CD21+ CD8+ RTE‐enriched subsets. PD‐1 and Ki67 expression did not explain this rise, indicating enhancement of thymic output despite the cohort's high median age. Patients requiring ICU care had lower CD31+ CD4+ RTE‐enriched subset frequencies in LC compared with non‐ICU cases. Regression coefficient modeling identified male sex as a negative predictor of CD31+ CD4+ RTE‐enriched subset frequency, potentially contributing to distinct CD31+ CD4+ and CD21+ CD8+ RTE‐enriched subset kinetics. Together, these findings suggest that de novo thymic output, particularly CD21+ CD8+ RTE‐enriched subset, contributes to T‐cell reconstitution after COVID‐19 and may influence susceptibility to post‐infectious immune dysregulation.
- 29 October 2026
- Published by Wiley in European Journal of Immunology
- Vol. 56 (10) , e70303
Open AccessIncreased Output of Recent Thymic Emigrants Contributes to Reconstitution of T‐Cell Pool During Recovery From COVID‐19
Acute coronavirus disease 2019 (COVID‐19) causes marked T‐cell lymphopenia, with recovery potentially driven by peripheral proliferation or increased thymic output of recent thymic emigrants (RTEs). We examined the relative contribution of these mechanisms by analyzing naïve T‐cell and RTE dynamics in 63 patients sampled at 1–3 timepoints during and after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Overall frequencies of naïve CD4+ and CD8+ T cells remained stable during convalescence. In a female‐biased subcohort with paired samples, CD31+ CD4+ and CD21+ CD8+ RTE‐enriched subset frequencies increased from acute to late convalescence (LC) stage. Across the full cohort, a significant increase was confirmed for CD21+ CD8+ RTE‐enriched subsets. PD‐1 and Ki67 expression did not explain this rise, indicating enhancement of thymic output despite the cohort's high median age. Patients requiring ICU care had lower CD31+ CD4+ RTE‐enriched subset frequencies in LC compared with non‐ICU cases. Regression coefficient modeling identified male sex as a negative predictor of CD31+ CD4+ RTE‐enriched subset frequency, potentially contributing to distinct CD31+ CD4+ and CD21+ CD8+ RTE‐enriched subset kinetics. Together, these findings suggest that de novo thymic output, particularly CD21+ CD8+ RTE‐enriched subset, contributes to T‐cell reconstitution after COVID‐19 and may influence susceptibility to post‐infectious immune dysregulation.
- Open Access
- 29 September 2026
- Published by Elsevier in CHEST Critical Care
Comparison of the Sequential Organ Failure Assessment 2 Score and the Original Sequential Organ Failure Assessment Score
- 29 September 2026
- Published by Elsevier in CHEST Critical Care
Open AccessComparison of the Sequential Organ Failure Assessment 2 Score and the Original Sequential Organ Failure Assessment Score
- Open Access
- 15 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70276
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events ( STEPCARE ‐ MAKE ): A Protocol for a Pre‐Planned Sub‐Study of a Randomized Clinical Trial
Background: Acute kidney injury (AKI) is a common and serious complication after cardiac arrest, affecting more than 30% of initially successfully resuscitated patients, with around 10% receiving Kidney Replacement Therapy (KRT). Currently, treatment options to prevent renal complications are limited. In this predefined sub‐study of the Sedation, TEmperature and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, we evaluate the effects of sedation depth, fever management strategies, and mean arterial pressure (MAP) targets on the risk of major adverse kidney events (MAKE) in post‐cardiac arrest patients. Methods: STEPCARE‐MAKE is a predefined prospective sub‐study of the international, randomized clinical STEPCARE trial. The main trial will enroll 3500 patients and employs a 2 × 2 × 2 factorial design, randomizing participants across three interventions: (1) deep sedation for 36 h or minimal sedation, (2) fever management with or without a feedback‐controlled device, and (3) MAP target ≥ 65 mmHg or ≥ 85 mmHg. The primary outcome is the composite outcome MAKE, which includes death from any cause by day 30, initiation of KRT, or persistent renal dysfunction, defined as the final creatinine value ≥ 200% of the baseline at the time of discharge from the primary hospital or at day 30, whichever occurs first. Differences between baseline and the highest in‐hospital creatinine, baseline and the last measured in‐hospital creatinine, baseline and 72‐h creatinine, and baseline and the highest creatinine within 72 h will be reported as secondary outcomes. Conclusion: The findings of this sub‐study will provide new evidence on the renal effects of the STEPCARE trial interventions and may inform the future of individualized kidney‐protective treatment approaches.
- 15 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70276
Open AccessEffects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events ( STEPCARE ‐ MAKE ): A Protocol for a Pre‐Planned Sub‐Study of a Randomized Clinical Trial
Background: Acute kidney injury (AKI) is a common and serious complication after cardiac arrest, affecting more than 30% of initially successfully resuscitated patients, with around 10% receiving Kidney Replacement Therapy (KRT). Currently, treatment options to prevent renal complications are limited. In this predefined sub‐study of the Sedation, TEmperature and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, we evaluate the effects of sedation depth, fever management strategies, and mean arterial pressure (MAP) targets on the risk of major adverse kidney events (MAKE) in post‐cardiac arrest patients. Methods: STEPCARE‐MAKE is a predefined prospective sub‐study of the international, randomized clinical STEPCARE trial. The main trial will enroll 3500 patients and employs a 2 × 2 × 2 factorial design, randomizing participants across three interventions: (1) deep sedation for 36 h or minimal sedation, (2) fever management with or without a feedback‐controlled device, and (3) MAP target ≥ 65 mmHg or ≥ 85 mmHg. The primary outcome is the composite outcome MAKE, which includes death from any cause by day 30, initiation of KRT, or persistent renal dysfunction, defined as the final creatinine value ≥ 200% of the baseline at the time of discharge from the primary hospital or at day 30, whichever occurs first. Differences between baseline and the highest in‐hospital creatinine, baseline and the last measured in‐hospital creatinine, baseline and 72‐h creatinine, and baseline and the highest creatinine within 72 h will be reported as secondary outcomes. Conclusion: The findings of this sub‐study will provide new evidence on the renal effects of the STEPCARE trial interventions and may inform the future of individualized kidney‐protective treatment approaches.
- Open Access
- 8 July 2025
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 69 (7) , e70087
Innate Immune Response After Cardiac Arrest (INNATUS): A Study Protocol for an Observational Single‐Center Pilot Study
Background: The treatment of cardiac arrest (CA) patients is often complicated by post‐cardiac arrest syndrome (PCAS), which involves a systemic inflammatory response. Increased levels of certain inflammatory markers (e.g., interleukin‐6 and procalcitonin) are associated with higher mortality and worse neurological outcomes. Previous studies have focused on the prognostic value of individual markers, whereas the interplay between inflammatory mediators in the setting of CA remains largely unclear. In this study, we aim to examine the patterns of inflammatory markers and their association with the severity of organ failure and 6‐month neurological outcomes in adult CA patients.Methods: This is a prospective observational single‐center study. The study cohort consists of 40 adult CA patients admitted to the ICU after successful resuscitation, and a control group of 40 patients undergoing elective coronary artery bypass graft (CABG) surgery. Patient enrollment started in January 2022 and was completed in April 2025. The last follow‐up samples and interviews are due in October 2025. We collect blood samples upon ICU admission, at 4, 8, 12, and 24 h after return of spontaneous circulation (ROSC) and on the mornings of treatment Days 1–4. We combine clinical data with proteomic, transcriptomic, and flow cytometric analyses of blood samples to generate a comprehensive systems immunology landscape of the PCAS. The control group of CABG patients is used to assess inflammatory changes related to surgical trauma and ICU treatment in general, with the goal of distinguishing inflammatory disturbances specific to CA. This allows the identification of complex inflammatory pathways relevant to the pathogenesis of PCAS. The gathered information can then be used to plan future anti‐inflammatory interventional trials. The primary outcomes of the study are the severity of organ failure during the first 96 h after ROSC and neurological outcome at 6 months. We will assess these using a modified SOFA score and the Modified Rankin Scale, respectively. We will use principal component analysis, latent profile analysis, and hierarchical clustering to identify patient subgroups with similar immunological response profiles. We will assess the correlation of different immunological response profiles with primary outcomes using linear mixed‐effects models.
- 8 July 2025
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 69 (7) , e70087
Open AccessInnate Immune Response After Cardiac Arrest (INNATUS): A Study Protocol for an Observational Single‐Center Pilot Study
Background: The treatment of cardiac arrest (CA) patients is often complicated by post‐cardiac arrest syndrome (PCAS), which involves a systemic inflammatory response. Increased levels of certain inflammatory markers (e.g., interleukin‐6 and procalcitonin) are associated with higher mortality and worse neurological outcomes. Previous studies have focused on the prognostic value of individual markers, whereas the interplay between inflammatory mediators in the setting of CA remains largely unclear. In this study, we aim to examine the patterns of inflammatory markers and their association with the severity of organ failure and 6‐month neurological outcomes in adult CA patients.Methods: This is a prospective observational single‐center study. The study cohort consists of 40 adult CA patients admitted to the ICU after successful resuscitation, and a control group of 40 patients undergoing elective coronary artery bypass graft (CABG) surgery. Patient enrollment started in January 2022 and was completed in April 2025. The last follow‐up samples and interviews are due in October 2025. We collect blood samples upon ICU admission, at 4, 8, 12, and 24 h after return of spontaneous circulation (ROSC) and on the mornings of treatment Days 1–4. We combine clinical data with proteomic, transcriptomic, and flow cytometric analyses of blood samples to generate a comprehensive systems immunology landscape of the PCAS. The control group of CABG patients is used to assess inflammatory changes related to surgical trauma and ICU treatment in general, with the goal of distinguishing inflammatory disturbances specific to CA. This allows the identification of complex inflammatory pathways relevant to the pathogenesis of PCAS. The gathered information can then be used to plan future anti‐inflammatory interventional trials. The primary outcomes of the study are the severity of organ failure during the first 96 h after ROSC and neurological outcome at 6 months. We will assess these using a modified SOFA score and the Modified Rankin Scale, respectively. We will use principal component analysis, latent profile analysis, and hierarchical clustering to identify patient subgroups with similar immunological response profiles. We will assess the correlation of different immunological response profiles with primary outcomes using linear mixed‐effects models.
- 8 October 2024
- Published by Elsevier in Resuscitation
- Vol. 203, 110382
Is the inflammatory response after cardiac arrest really a “cytokine storm”?
- 8 October 2024
- Published by Elsevier in Resuscitation
- Vol. 203, 110382
Is the inflammatory response after cardiac arrest really a “cytokine storm”?
- Open Access
- 20 June 2023
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (9) , 1273-1287
Inflammatory response after out‐of‐hospital cardiac arrest—Impact on outcome and organ failure development
Background: Post‐cardiac arrest syndrome that occurs in out‐of‐hospital cardiac arrest (OHCA) patients is characterized by inflammatory response. We conducted a scoping review of current evidence regarding several inflammatory markers' usefulness for assessment of patient outcome and illness severity. We also discuss the proposed underlying mechanisms leading to inflammatory response after OHCA.Methods: We searched the MEDLINE, PubMed Central, Cochrane CENTRAL and Web of Science Core Collection databases with the following search terms: (“inflammation” OR “cytokines”) AND “out‐of‐hospital cardiac arrest.” Each inflammatory marker found was combined with “out‐of‐hospital cardiac arrest” using “AND” to find further relevant studies. We included original studies measuring inflammatory markers in adult OHCA patients that assessed their prognostic capabilities for mortality, neurological outcome, or organ failure severity.Results: Fifty‐nine studies met the inclusion criteria, covering in total 65 different markers. Interleukin‐6 (IL‐6), procalcitonin (PCT) and C‐reactive protein (CRP) were the most studied markers, and they were associated with poor outcomes in 13/15, 13/14 and 11/17 studies, respectively. Based on area under the receiver operating characteristic curve (AUC) value, the time point of best discriminatory capacity for poor outcome was ICU admission for IL‐6 (median AUC 0.78, range 0.71–0.98) and day one after OHCA for PCT (median AUC 0.84, range 0.61–0.98). Seven studies reported AUCs for CRP (range 0.52–0.76) with no measurement time point being superior to others. The association of IL‐6 and PCT with outcome appeared stronger in studies with more severely ill patients. Studies reported conflicting results regarding each marker's association with organ failure severity.Conclusion: Inflammatory markers are potentially useful for early risk stratification after OHCA. PCT and IL‐6 have moderate prognostic value during the first 24 h of the ICU stay. Predictive accuracy appears to be associated with the study overall event rate.
- 20 June 2023
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (9) , 1273-1287
Open AccessInflammatory response after out‐of‐hospital cardiac arrest—Impact on outcome and organ failure development
Background: Post‐cardiac arrest syndrome that occurs in out‐of‐hospital cardiac arrest (OHCA) patients is characterized by inflammatory response. We conducted a scoping review of current evidence regarding several inflammatory markers' usefulness for assessment of patient outcome and illness severity. We also discuss the proposed underlying mechanisms leading to inflammatory response after OHCA.Methods: We searched the MEDLINE, PubMed Central, Cochrane CENTRAL and Web of Science Core Collection databases with the following search terms: (“inflammation” OR “cytokines”) AND “out‐of‐hospital cardiac arrest.” Each inflammatory marker found was combined with “out‐of‐hospital cardiac arrest” using “AND” to find further relevant studies. We included original studies measuring inflammatory markers in adult OHCA patients that assessed their prognostic capabilities for mortality, neurological outcome, or organ failure severity.Results: Fifty‐nine studies met the inclusion criteria, covering in total 65 different markers. Interleukin‐6 (IL‐6), procalcitonin (PCT) and C‐reactive protein (CRP) were the most studied markers, and they were associated with poor outcomes in 13/15, 13/14 and 11/17 studies, respectively. Based on area under the receiver operating characteristic curve (AUC) value, the time point of best discriminatory capacity for poor outcome was ICU admission for IL‐6 (median AUC 0.78, range 0.71–0.98) and day one after OHCA for PCT (median AUC 0.84, range 0.61–0.98). Seven studies reported AUCs for CRP (range 0.52–0.76) with no measurement time point being superior to others. The association of IL‐6 and PCT with outcome appeared stronger in studies with more severely ill patients. Studies reported conflicting results regarding each marker's association with organ failure severity.Conclusion: Inflammatory markers are potentially useful for early risk stratification after OHCA. PCT and IL‐6 have moderate prognostic value during the first 24 h of the ICU stay. Predictive accuracy appears to be associated with the study overall event rate.
- Open Access
- 5 June 2023
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (9) , 1219-1228
Vasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care
Background: The cardiovascular component of the sequential organ failure assessment (cvSOFA) score may be outdated because of changes in intensive care. Vasoactive Inotropic Score (VIS) represents the weighted sum of vasoactive and inotropic drugs. We investigated the association of VIS with mortality in the general intensive care unit (ICU) population and studied whether replacing cvSOFA with a VIS‐based score improves the accuracy of the SOFA score as a predictor of mortality.Methods: We studied the association of VIS during the first 24 h after ICU admission with 30‐day mortality in a retrospective study on adult medical and non‐cardiac emergency surgical patients admitted to Kuopio University Hospital ICU, Finland, in 2013–2019. We determined the area under the receiver operating characteristic curve (AUROC) for the original SOFA and for SOFAVISmax, where cvSOFA was replaced with maximum VIS (VISmax) categories.Results: Of 8079 patients, 1107 (13%) died within 30 days. Mortality increased with increasing VISmax. AUROC was 0.813 (95% confidence interval [CI], 0.800–0.825) for original SOFA and 0.822 (95% CI: 0.810–0.834) for SOFAVISmax, p < .001.Conclusion: Mortality increased consistently with increasing VISmax. Replacing cvSOFA with VISmax improved the predictive accuracy of the SOFA score.
- 5 June 2023
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (9) , 1219-1228
Open AccessVasoactive Inotropic Score compared to the sequential organ failure assessment cardiovascular score in intensive care
Background: The cardiovascular component of the sequential organ failure assessment (cvSOFA) score may be outdated because of changes in intensive care. Vasoactive Inotropic Score (VIS) represents the weighted sum of vasoactive and inotropic drugs. We investigated the association of VIS with mortality in the general intensive care unit (ICU) population and studied whether replacing cvSOFA with a VIS‐based score improves the accuracy of the SOFA score as a predictor of mortality.Methods: We studied the association of VIS during the first 24 h after ICU admission with 30‐day mortality in a retrospective study on adult medical and non‐cardiac emergency surgical patients admitted to Kuopio University Hospital ICU, Finland, in 2013–2019. We determined the area under the receiver operating characteristic curve (AUROC) for the original SOFA and for SOFAVISmax, where cvSOFA was replaced with maximum VIS (VISmax) categories.Results: Of 8079 patients, 1107 (13%) died within 30 days. Mortality increased with increasing VISmax. AUROC was 0.813 (95% confidence interval [CI], 0.800–0.825) for original SOFA and 0.822 (95% CI: 0.810–0.834) for SOFAVISmax, p < .001.Conclusion: Mortality increased consistently with increasing VISmax. Replacing cvSOFA with VISmax improved the predictive accuracy of the SOFA score.
- Open Access
- 1 November 2022
- Published by Wiley in Cytometry Part A
- Vol. 103 (4) , 313-324
A comprehensive assessment of four whole blood stabilizers for flow‐cytometric analysis of leukocyte populations
Though cryopreservation of cell fractions is widely used in flow cytometry studies, whole blood cryopreservation is more challenging due to the presence of erythrocytes and effects of fixatives commonly used for preservation. Here, we evaluated and compared head‐to‐head the performance of four commercial whole blood cryopreservation kits; (1) Cytodelics, (2) Stable‐Lyse V2 and Stable‐Store V2 (SLSS‐V2), (3) Proteomic stabilizer (PROT‐1), and (4) Transfix. We found that PROT‐1, Transfix, and Cytodelics maintained the distribution of major leukocyte subsets—granulocytes, T cells, natural killer cells, and B cells, on a comparable level to unpreserved samples, despite the attenuation of fluorescence intensities in flow cytometric assays. Moreover, these three stabilizers also maintained the activated phenotypes of neutrophils upon stimulation with N‐formylmethionyl‐leucyl‐phenylalanine and lipopolysaccharides. The upregulation of adhesion molecules (CD11b), Fc receptors (CD16), and granule proteins (CD66b), as well as the shedding of surface L‐selectin (CD62L), was conserved most efficiently in PROT‐1 and Cytodelics when compared to samples only treated with erythrocyte lysing. However, none of the stabilizers provided a reliable detection of CCR7 for accurate quantification of T cell maturation stages. We also evaluated the performance of Cytodelics in longitudinal clinical samples obtained from acute COVID‐19 patients, where it allowed reliable detection of lymphopenia and granulocyte expansion. These results support the feasibility of whole blood cryopreservation for immunophenotyping by flow cytometry, particularly in longitudinal studies. In conclusion, the performance of different stabilizers is variable and therefore the choice of stabilizers should depend on cell type of interest, as well as antibody clones and experimental design of each study.
- 1 November 2022
- Published by Wiley in Cytometry Part A
- Vol. 103 (4) , 313-324
Open AccessA comprehensive assessment of four whole blood stabilizers for flow‐cytometric analysis of leukocyte populations
Though cryopreservation of cell fractions is widely used in flow cytometry studies, whole blood cryopreservation is more challenging due to the presence of erythrocytes and effects of fixatives commonly used for preservation. Here, we evaluated and compared head‐to‐head the performance of four commercial whole blood cryopreservation kits; (1) Cytodelics, (2) Stable‐Lyse V2 and Stable‐Store V2 (SLSS‐V2), (3) Proteomic stabilizer (PROT‐1), and (4) Transfix. We found that PROT‐1, Transfix, and Cytodelics maintained the distribution of major leukocyte subsets—granulocytes, T cells, natural killer cells, and B cells, on a comparable level to unpreserved samples, despite the attenuation of fluorescence intensities in flow cytometric assays. Moreover, these three stabilizers also maintained the activated phenotypes of neutrophils upon stimulation with N‐formylmethionyl‐leucyl‐phenylalanine and lipopolysaccharides. The upregulation of adhesion molecules (CD11b), Fc receptors (CD16), and granule proteins (CD66b), as well as the shedding of surface L‐selectin (CD62L), was conserved most efficiently in PROT‐1 and Cytodelics when compared to samples only treated with erythrocyte lysing. However, none of the stabilizers provided a reliable detection of CCR7 for accurate quantification of T cell maturation stages. We also evaluated the performance of Cytodelics in longitudinal clinical samples obtained from acute COVID‐19 patients, where it allowed reliable detection of lymphopenia and granulocyte expansion. These results support the feasibility of whole blood cryopreservation for immunophenotyping by flow cytometry, particularly in longitudinal studies. In conclusion, the performance of different stabilizers is variable and therefore the choice of stabilizers should depend on cell type of interest, as well as antibody clones and experimental design of each study.
- Open Access
- 12 September 2022
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (1) , 94-103
Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest
Background: Achieving an acceptable neurological outcome in cardiac arrest survivors remains challenging. Ischemia‐reperfusion injury induces inflammation, which may cause secondary neurological damage. We studied the association of ICU admission levels of inflammatory biomarkers with disturbed 48‐hour continuous electroencephalogram (cEEG), and the association of the daily levels of these markers up to 72 h with poor 6‐month neurological outcome.Methods: This is an observational, post hoc sub‐study of the COMACARE trial. We measured serum concentrations of procalcitonin (PCT), high‐sensitivity C‐reactive protein (hsCRP), osteopontin (OPN), myeloperoxidase (MPO), resistin, and proprotein convertase subtilisin/kexin type 9 (PCSK9) in 112 unconscious, mechanically ventilated ICU‐treated adult OHCA survivors with initial shockable rhythm. We used grading of 48‐hour cEEG monitoring as a measure for the severity of the early neurological disturbance. We defined 6‐month cerebral performance category (CPC) 1–2 as good and CPC 3–5 as poor long‐term neurological outcome. We compared the prognostic value of biomarkers for 6‐month neurological outcome to neurofilament light (NFL) measured at 48 h.Results: Higher OPN (p = .03), MPO (p < .01), and resistin (p = .01) concentrations at ICU admission were associated with poor grade 48‐hour cEEG. Higher levels of ICU admission OPN (OR 3.18; 95% CI 1.25–8.11 per ln[ng/ml]) and MPO (OR 2.34; 95% CI 1.30–4.21) were independently associated with poor 48‐hour cEEG in a multivariable logistic regression model. Poor 6‐month neurological outcome was more common in the poor cEEG group (63% vs. 19% p < .001, respectively). We found a significant fixed effect of poor 6‐month neurological outcome on concentrations of PCT (F = 7.7, p < .01), hsCRP (F = 4.0, p < .05), and OPN (F = 5.6, p < .05) measured daily from ICU admission to 72 h. However, the biomarkers did not have independent predictive value for poor 6‐month outcome in a multivariable logistic regression model with 48‐hour NFL.Conclusion: Elevated ICU admission levels of OPN and MPO predicted disturbances in cEEG during the subsequent 48 h after cardiac arrest. Thus, they may provide early information about the risk of secondary neurological damage. However, the studied inflammatory markers had little value for long‐term prognostication compared to 48‐hour NFL.
- 12 September 2022
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 67 (1) , 94-103
Open AccessMarkers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest
Background: Achieving an acceptable neurological outcome in cardiac arrest survivors remains challenging. Ischemia‐reperfusion injury induces inflammation, which may cause secondary neurological damage. We studied the association of ICU admission levels of inflammatory biomarkers with disturbed 48‐hour continuous electroencephalogram (cEEG), and the association of the daily levels of these markers up to 72 h with poor 6‐month neurological outcome.Methods: This is an observational, post hoc sub‐study of the COMACARE trial. We measured serum concentrations of procalcitonin (PCT), high‐sensitivity C‐reactive protein (hsCRP), osteopontin (OPN), myeloperoxidase (MPO), resistin, and proprotein convertase subtilisin/kexin type 9 (PCSK9) in 112 unconscious, mechanically ventilated ICU‐treated adult OHCA survivors with initial shockable rhythm. We used grading of 48‐hour cEEG monitoring as a measure for the severity of the early neurological disturbance. We defined 6‐month cerebral performance category (CPC) 1–2 as good and CPC 3–5 as poor long‐term neurological outcome. We compared the prognostic value of biomarkers for 6‐month neurological outcome to neurofilament light (NFL) measured at 48 h.Results: Higher OPN (p = .03), MPO (p < .01), and resistin (p = .01) concentrations at ICU admission were associated with poor grade 48‐hour cEEG. Higher levels of ICU admission OPN (OR 3.18; 95% CI 1.25–8.11 per ln[ng/ml]) and MPO (OR 2.34; 95% CI 1.30–4.21) were independently associated with poor 48‐hour cEEG in a multivariable logistic regression model. Poor 6‐month neurological outcome was more common in the poor cEEG group (63% vs. 19% p < .001, respectively). We found a significant fixed effect of poor 6‐month neurological outcome on concentrations of PCT (F = 7.7, p < .01), hsCRP (F = 4.0, p < .05), and OPN (F = 5.6, p < .05) measured daily from ICU admission to 72 h. However, the biomarkers did not have independent predictive value for poor 6‐month outcome in a multivariable logistic regression model with 48‐hour NFL.Conclusion: Elevated ICU admission levels of OPN and MPO predicted disturbances in cEEG during the subsequent 48 h after cardiac arrest. Thus, they may provide early information about the risk of secondary neurological damage. However, the studied inflammatory markers had little value for long‐term prognostication compared to 48‐hour NFL.
- Open Access
- 10 April 2022
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 66 (6) , 731-741
Association of Sequential Organ Failure Assessment (SOFA) components with mortality
Background: Sequential Organ Failure Assessment (SOFA) is a practical method to describe and quantify the presence and severity of organ system dysfunctions and failures. Some proposals suggest that SOFA could be employed as an endpoint in trials. To justify this, all SOFA component scores should reflect organ dysfunctions of comparable severity. We aimed to investigate whether the associations of different SOFA components with in‐hospital mortality are comparable.Methods: We performed a study based on nationwide register data on adult patients admitted to 26 Finnish intensive care units (ICUs) during 2012−2015. We determined the SOFA score as the maximum score in the first 24 hours after ICU admission. We defined organ failure (OF) as an organ‐specific SOFA score of three or higher. We evaluated the association of different SOFA component scores with mortality.Results: Our study population comprised 63,756 ICU patients. Overall hospital mortality was 10.7%. In‐hospital mortality was 22.5% for patients with respiratory failure, 34.8% for those with coagulation failure, 40.1% for those with hepatic failure, 14.9% for those with cardiovascular failure, 26.9% for those with neurologic failure and 34.6% for the patients with renal failure. Among patients with comparable total SOFA scores, the risk of death was lower in patients with cardiovascular OF compared with patients with other OFs.Conclusions: All SOFA components are associated with mortality, but their weights are not comparable. High scores of other organ systems mean a higher risk of death than high cardiovascular scores. The scoring of cardiovascular dysfunction needs to be updated.
- 10 April 2022
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 66 (6) , 731-741
Open AccessAssociation of Sequential Organ Failure Assessment (SOFA) components with mortality
Background: Sequential Organ Failure Assessment (SOFA) is a practical method to describe and quantify the presence and severity of organ system dysfunctions and failures. Some proposals suggest that SOFA could be employed as an endpoint in trials. To justify this, all SOFA component scores should reflect organ dysfunctions of comparable severity. We aimed to investigate whether the associations of different SOFA components with in‐hospital mortality are comparable.Methods: We performed a study based on nationwide register data on adult patients admitted to 26 Finnish intensive care units (ICUs) during 2012−2015. We determined the SOFA score as the maximum score in the first 24 hours after ICU admission. We defined organ failure (OF) as an organ‐specific SOFA score of three or higher. We evaluated the association of different SOFA component scores with mortality.Results: Our study population comprised 63,756 ICU patients. Overall hospital mortality was 10.7%. In‐hospital mortality was 22.5% for patients with respiratory failure, 34.8% for those with coagulation failure, 40.1% for those with hepatic failure, 14.9% for those with cardiovascular failure, 26.9% for those with neurologic failure and 34.6% for the patients with renal failure. Among patients with comparable total SOFA scores, the risk of death was lower in patients with cardiovascular OF compared with patients with other OFs.Conclusions: All SOFA components are associated with mortality, but their weights are not comparable. High scores of other organ systems mean a higher risk of death than high cardiovascular scores. The scoring of cardiovascular dysfunction needs to be updated.